Although preventive effects have been achieved in TNBC and HER2 positive BC, vaccines targeting hormone receptor positive subtypes of breast cancer have not yet been reported, which also emphasizes the importance of a comprehensive understanding of breast carcinogenesis and cancer immune modulation. This evidence concerns the gene NR4A1 and breast cancer.